orforglipron vs semaglutide Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes obesity #diabetes #endocrinology #glp1 #obesitytreatment

When glutathione does its job and becomes oxidized, vitamin C can step in to provide the electrons needed to turn it back into its active, "reduced" state

Notably, GLP-1 analogs that can pass the BBB have been shown to produce strong neuroprotective effects in preclinical models of Alzheimers disease, Parkinsons disease, stroke, and other neurological conditions

Therefore, we proposed to delete HCPCS code C9751 for CY 2026

While consensus does not exist regarding the exact synergistic mechanisms by which dual-agonists work, the addition of GIP agonism is posited to improve the HbA1c control and weight loss offered by GLP-1 agonists alone by enhancing insulin secretion, decreasing energy consumption, and stimulating satiety in the hypothalamus